Page last updated: 2024-11-09

cuscohygrine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cuscohygrine: RN given for (R*,S*)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1201543
CHEBI ID27920
SCHEMBL ID336171
MeSH IDM0258313

Synonyms (25)

Synonym
cuscohygrine
454-14-8
cuskhygrine
1-[(2r)-1-methylpyrrolidin-2-yl]-3-[(2s)-1-methylpyrrolidin-2-yl]propan-2-one
1-[(2r)-1-methylpyrrolidin-2-yl]-3-[(2s)-1-methylpyrrolidin-2-yl]acetone
(r*,s*)-1,3-bis(1-methyl-2-pyrrolidinyl)-2-propanone
CHEBI:27920
meso-cuscohygrine
93fj3823vl ,
2-propanone, 1,3-bis(1-methyl-2-pyrrolidinyl)-, (r*,s*)-
unii-93fj3823vl
bellaradin
cuskhygrin
bellaradine
cuscohygrine [mi]
cuscohygrine [who-dd]
2-propanone, 1-((2r)-1-methyl-2-pyrrolidinyl)-3-((2s)-1-methyl-2-pyrrolidinyl)-, rel-
cuscohygrine, meso-
SCHEMBL336171
J-520125
DTXSID70894079
Q3007886
1-[(2s)-1-methylpyrrolidin-2-yl]-3-[(2r)-1-methylpyrrolidin-2-yl]propan-2-one
1-((r)-1-methylpyrrolidin-2-yl)-3-((s)-1-methylpyrrolidin-2-yl)propan-2-one
1,3-bis(1-methylpyrrolidin-2-yl)acetone

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
pyrrolidine alkaloid
N-alkylpyrrolidine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (9.09)18.7374
1990's1 (9.09)18.2507
2000's1 (9.09)29.6817
2010's7 (63.64)24.3611
2020's1 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.64 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index5.45 (4.65)
Search Engine Demand Index79.51 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (52.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]